Related Experiment Video
Updated: Aug 27, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
[What future for ribavirin beyond hepatitis C therapy?]
H Jeulin1, F Kedzierewicz2, N Grancher3
1Laboratoire de virologie, centre hospitalier universitaire de Nancy, Groupe d'étude des vecteurs supramoléculaires du médicament, faculté de pharmacie, UMR 7565 CNRS-Nancy Université, Adresse actuelle: Laboratoire de virologie, centre hospitalier universitaire de Nancy - EA RHEM 4369, faculté de médecine, Nancy Université.
Ribavirin, an antiviral drug, shows broad-spectrum activity against RNA viruses. Enhancing its delivery using cyclodextrins could improve treatments for viral diseases, including encephalitis.
Area of Science:
- Virology
- Pharmacology
- Drug Delivery
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Retrovirus Life Cycles
Retroviruses
Hepatic Drug Excretion: Influencing Factors
Subviral Agents
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

